Welcome to the seventh annual “Women Leadership in Immuno-Oncology” Issue.
This issue highlights six incredibly accomplished women, ranging from chief scientific officers, program directors and department heads, leading scientific programs and initiatives and leveraging cutting-edge advances in technology and biology to advance the field of immuno-oncology.
This issue is a sampling of the many incredible women who are working to advance the field of immuno-oncology; we honor all the women who are working to make a difference in fighting cancer.
These women discuss how they are impacting immuno-oncology, look back on their career journeys and provide advice for the next generation of executive and academic scientists in the field.
We are honored to highlight these individuals, and thank them for their achievements and contributions in immuno-oncology and for participating in our annual series.
This year's edition includes:
Andrea Cercek, MD, Physician-Scientist & Medical Oncologist; Section Head of Colorectal Cancer; Founder and co-director of the Center for Young Onset Colorectal and Gastrointestinal Cancer, Memorial Sloan Kettering Cancer Center
Click here to read Dr Cercek's interview
Sruthi Ravindranathan, PhD, Senior Scientist, Translational Medicine, Coherus Oncology
Click here to read Dr Ravindranathan's interview
Barbra Sasu, PhD, Chief Scientific Officer, Dispatch Bio
Click here to read Dr Sasu's interview
I-hung Shih, PhD, MBA, Managing Director & Portfolio Manager, Eventide Asset Management
Click here to read Dr Shih's interview
Anna Truppel-Hartmann, MD, Chief Medical Officer, KSQ Therapeutics
Click here to read Dr Truppel-Hartmann's interview
Elizabeth Wood, PhD, Chief Executive Officer & Founder, Jura Bio, Inc
Click here to read Dr Wood's interview
Enjoy the interviews.
Danny McCarthy,
Senior Content Editor
Kate Woda
Senior Director
